Bulletin
Investor Alert

Company Close Updates Archives | Email alerts

Dec. 9, 2020, 5:07 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock falls Wednesday, underperforms market

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slipped 3.61% to $1.33 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.94% to 12,338.95 and Dow Jones Industrial Average DJIA falling 0.35% to 30,068.81. Corbus Pharmaceuticals Holdings Inc. closed $8.45 short of its 52-week high ($9.78), which the company reached on August 31st.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Fate Therapeutics Inc. FATE fell 5.46% to $86.60, Vanda Pharmaceuticals Inc. VNDA fell 1.98% to $13.38, and Viking Therapeutics Inc. VKTX fell 4.24% to $5.98. Trading volume (3.6 M) remained 958,242 below its 50-day average volume of 4.6 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.